Holen Sie sich die Stockscreener-App
0.7792
2.10%
-0.0167
Schlusskurs vom Vortag:
$0.7959
Offen:
$0.8
24-Stunden-Volumen:
130.72K
Relative Volume:
0.55
Marktkapitalisierung:
$28.39M
Einnahmen:
$3.81M
Nettoeinkommen (Verlust:
$-7.29M
KGV:
-3.6428
EPS:
-0.2139
Netto-Cashflow:
$-5.72M
1W Leistung:
+15.37%
1M Leistung:
+7.92%
6M Leistung:
-14.30%
1J Leistung:
-16.22%
1-Tages-Spanne:
$0.75
$0.81
1-Wochen-Bereich:
$0.6568
$0.81
52-Wochen-Spanne:
$0.6546
$1.346
Dyadic International Inc De Stock (DYAI) Company Profile
Firmenname
Dyadic International Inc De
Sektor
Branche
Telefon
561-743-8333
Adresse
1044 NORTH U.S. HIGHWAY ONE, JUPITER
Compare DYAI vs MOBBW, SHMD, GOODO, PSNYW, DWLD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| 1.69 | 0 | 0 | 0 | 0 | 0.00 | |
MOBBW
Mobilicom Limited Warrants
|
2.45 | 3.33B | 0 | 0 | 0 | 0.00 |
SHMD
Schmid Group N V
|
6.19 | 397.06M | 52.15M | -21.46M | 0 | -0.4675 |
GOODO
Gladstone Commercial Corporation
|
20.19 | 372.90M | 0 | 0 | 0 | 0.00 |
PSNYW
Polestar Automotive Holding Uk
|
2.83 | 254.39M | 2.07B | -1.42B | -1.37B | -0.6765 |
DWLD
Davis Select Worldwide ETF
|
47.19 | 0 | 0 | 0 | 0 | 0.00 |
Dyadic International Inc De Stock (DYAI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-23 | Fortgesetzt | H.C. Wainwright | Buy |
| 2025-09-08 | Eingeleitet | Craig Hallum | Buy |
| 2022-07-18 | Herabstufung | Dawson James | Buy → Neutral |
| 2021-12-17 | Eingeleitet | H.C. Wainwright | Buy |
Dyadic International Inc De Aktie (DYAI) Neueste Nachrichten
Dyadic Showcases C1 Platform Amid Ebola Preparedness Surge - TipRanks
De-Inking Enzymes Market is Booming Worldwide | Major Giants Megazyme, BASF SE, DuPont - openPR.com
Enzyme Stabilizer Market Trends Support A 6.7% CAGR Outlook Through The Forecast Period - openPR.com
Analysts Have Conflicting Sentiments on These Consumer Goods Companies: BioHarvest Sciences (BHST) and Brown Forman A (BF.A) - The Globe and Mail
Dyadic Under $1 as Investors Eye June Vote - Bez Kabli
Analysts Offer Insights on Healthcare Companies: Repligen (RGEN), Vaxcyte (PCVX) and BeOne Medicines (ONC) - The Globe and Mail
Dyadic International Launches Recombinant Human Albumin and Bovine Chymosin - asatunews.co.id
Analysts Offer Insights on Industrial Goods Companies: DroneShield Limited (OtherDRSHF), CryoPort (CYRX) and Deere (DE) - The Globe and Mail
Dyadic International (DYAI) Surges 13.8% – Key Levels in FocusETF AUM Growth - newsline.com
Dyadic and Scripps Research Partner to Accelerate Hantavirus Antibody and Vaccine Development Using C1 Biologic Platform - Minichart
Skyline Corporate Communications Group, LLC Announces Dyadic Applied BioSolutions to Deliver a Live Presentation at the Skyline Signature Series™ on Wednesday, May 27 at 12:00 PM ET - GlobeNewswire Inc.
Skyline Corporate Communications Group, LLC Announces - GlobeNewswire
Dyadic International’s Earnings Call Shows Early Momentum - The Globe and Mail
Dyadic International Earnings Call Highlights Early Momentum - TipRanks
Earnings call transcript: Dyadic’s Q1 2026 revenue surges 182% despite EPS miss By Investing.com - Investing.com Australia
Japan’s First LNG Shipment via Hormuz Since Strait’s De Facto Closure Marks Energy Security MilestoneAnalyst Coverage Count - The Legal Advocate
Dyadic International stock (US26746E1055): Shares climb after recent momentum - AD HOC NEWS
Dyadic International, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
Earnings call transcript: Dyadic International Q1 2026 revenue beats forecast, stock dips - Investing.com India
Earnings call transcript: Dyadic International Q1 2026 revenue beats forecast, stock dips By Investing.com - Investing.com India
Transcript: Dyadic International Q1 2026 Earnings Conference Call - Benzinga
Dyadic International (NASDAQ: DYAI) grows Q1 2026 revenue but flags going-concern risks - Stock Titan
Specialty Enzymes Market Overview, Emerging Trends, and Key Player Analysis - openPR.com
Analysis of Segments and Major Growth Areas in the Protein Hydrolysis Enzymes Market - openPR.com
Unusual VolumeStock ScreenerNews - Finviz
Biogen Inc. (BIIB)Dual Wall Street Upgrades Signal Bullish Pipeline Catalyst UpsideAnalyst Coverage Count - newsline.com
Dyadic International stock (US26746E1055): Is its biotech platform strong enough to unlock new upsid - AD HOC NEWS
Dyadic International Stock: Biotechnology Innovator Focused on C1 Platform Amid Earnings Challenges - AD HOC NEWS
Dyadic International Earnings Call Highlights Commercial Pivot - TipRanks
Dyadic International, Inc.'s (NASDAQ:DYAI) Path To Profitability - simplywall.st
Dyadic International Q4 2025 Earnings Call Transcript - MarketBeat
Dyadic Applied BioSolutions Reports 2025 Financial Results, Commercial Launches, and Strategic Partnerships in Animal-Free Protein Production 12346 - Minichart
Dyadic Applied BioSolutions: Innovative Microbial Protein Production Platforms for Life Sciences, Food, and Industrial Markets - Minichart
Dyadic International Inc (DYAI) Q4 2025 Earnings Call Highlights: Navigating Transition with ... By GuruFocus - ca.investing.com
Dyadic International’s ability to sustain operations for the next year and avoid significant dilution depends on the effectiveness of its shift toward commercial strategies - Bitget
Dyadic (DYAI) Q4 2025 Earnings Call Transcript - theglobeandmail.com
Earnings call transcript: Dyadic Q4 2025 reveals revenue decline, stock up 3.32% - Investing.com Australia
Dyadic Announces 2025 Financial Results and Highlights Recent Company Progress - Yahoo Finance Singapore
Dyadic (NASDAQ: DYAI) posts lower 2025 revenue and wider annual net loss - Stock Titan
Dyadic International, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
EXCLUSIVE: Co-Diagnostics Expands South Asia Reach, Targets $13 Billion Market Opportunity - AOL.com
Dyadic Applied BioSolutions Announces Commercial Distribution Partnership with IBT Bioservices - GlobeNewswire
Dyadic to Report 2025 Full Year Financial Results and Host Conference Call on Wednesday, March 25, 2026 - The Manila Times
Dyadic to detail full-year 2025 results in March 25 investor call - Stock Titan
Life Sciences Virtual Investor Forum Agenda Announced for March 11th & 12th - GlobeNewswire
Decliners Report: Can Dyadic International Inc outperform under higher oil pricesWeekly Market Outlook & Free Accurate Trade Setup Notifications - baoquankhu1.vn
Dyadic International Establishes At-the-Market Equity Offering Program - The Globe and Mail
Dyadic and Fermbox Bio Launch First Product Under Expanded - GlobeNewswire
Dyadic Applied BioSolutions and Inzymes ApS Announce - GlobeNewswire
Dyadic Applied BioSolutions and Inzymes ApS Announce Planned 2026 Commercialization of Non-Animal Dairy Enzyme Following Achievement of Development Milestone - Yahoo Finance
Dyadic's Strategic Pivot: From Platform to Product - AD HOC NEWS
Finanzdaten der Dyadic International Inc De-Aktie (DYAI)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.27%
1.43%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):